X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4138) 4138
Book Review (573) 573
Publication (220) 220
Book Chapter (13) 13
Conference Proceeding (10) 10
Book / eBook (1) 1
Dissertation (1) 1
Government Document (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3737) 3737
humans (3439) 3439
mycophenolic acid - analogs & derivatives (2809) 2809
male (2318) 2318
female (2236) 2236
mycophenolic acid - therapeutic use (1817) 1817
transplantation (1767) 1767
adult (1766) 1766
middle aged (1686) 1686
immunosuppressive agents - therapeutic use (1651) 1651
mycophenolic acid - administration & dosage (1579) 1579
immunosuppressive agents - administration & dosage (1374) 1374
mycophenolate mofetil (1362) 1362
surgery (1056) 1056
drug therapy, combination (984) 984
immunology (954) 954
mycophenolic acid (871) 871
treatment outcome (868) 868
kidney transplantation (807) 807
immunosuppressive agents - adverse effects (794) 794
aged (780) 780
tacrolimus (766) 766
mycophenolic acid - adverse effects (741) 741
cyclosporine (706) 706
graft rejection - prevention & control (608) 608
mycophenolic acid - pharmacokinetics (606) 606
pharmacology & pharmacy (602) 602
immunosuppression (590) 590
animals (578) 578
adolescent (577) 577
immunosuppressive agents - pharmacokinetics (548) 548
retrospective studies (531) 531
kidneys (529) 529
recipients (526) 526
pharmacokinetics (513) 513
time factors (502) 502
cyclosporine - therapeutic use (496) 496
tacrolimus - administration & dosage (486) 486
tacrolimus - therapeutic use (474) 474
therapy (468) 468
mofetil (457) 457
kidney transplantation - immunology (454) 454
cyclosporine - administration & dosage (439) 439
mycophenolate-mofetil (420) 420
follow-up studies (418) 418
child (413) 413
mycophenolic acid - pharmacology (412) 412
prospective studies (396) 396
immunosuppressive agents (393) 393
acute rejection (391) 391
urology & nephrology (388) 388
dose-response relationship, drug (376) 376
drug administration schedule (366) 366
young adult (355) 355
calcineurin inhibitors (331) 331
analysis (325) 325
kidney-transplantation (321) 321
mycophenolic acid - blood (314) 314
immunosuppressive agents - pharmacology (312) 312
area under curve (309) 309
acid (299) 299
immunotherapy (299) 299
renal-transplantation (297) 297
risk factors (289) 289
prevention (273) 273
organ transplant recipients (272) 272
rejection (271) 271
transplants & implants (262) 262
health aspects (258) 258
drug therapy (256) 256
azathioprine - therapeutic use (255) 255
immunosuppressive agents - blood (249) 249
azathioprine (242) 242
rats (242) 242
kidney transplantation - adverse effects (241) 241
corticosteroids (238) 238
efficacy (237) 237
mycophenolic-acid (236) 236
graft rejection - drug therapy (235) 235
graft survival (232) 232
cyclophosphamide (230) 230
pediatrics (224) 224
transplantation, homologous (224) 224
graft survival - drug effects (222) 222
hematology (222) 222
disease (217) 217
abridged index medicus (216) 216
administration, oral (216) 216
research (214) 214
rheumatology (208) 208
care and treatment (205) 205
child, preschool (205) 205
antibodies, monoclonal - therapeutic use (204) 204
children (204) 204
sirolimus (204) 204
biopsy (201) 201
dosage and administration (198) 198
medicine & public health (197) 197
prednisone - therapeutic use (196) 196
adrenal cortex hormones - therapeutic use (195) 195
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3990) 3990
Japanese (35) 35
German (32) 32
Spanish (27) 27
Chinese (24) 24
French (16) 16
Polish (7) 7
Hungarian (4) 4
Italian (3) 3
Serbian (3) 3
Czech (2) 2
Norwegian (2) 2
Portuguese (2) 2
Croatian (1) 1
Dutch (1) 1
Lithuanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Index Medicus | Abridged Index Medicus | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 6, pp. 641 - 650
Abstract We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease... 
Hematology, Oncology and Palliative Medicine | Bone marrow transplantation | Cyclophosphamide | Histocompatibility antigens | Conditioning regimens | Lymphoma | Leukemia | TOTAL-BODY IRRADIATION | leukemia | IMMUNE RECONSTITUTION | lymphoma | UNRELATED DONORS | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | VERSUS-HOST-DISEASE | bone marrow transplantation | TRANSPLANTATION | histocompatibility antigens | CORD BLOOD TRANSPLANTATION | DRUG-INDUCED TOLERANCE | IDENTICAL SIBLINGS | cyclophosphamide | STEM-CELL TRANSPLANTATION | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | conditioning regimens | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Graft vs Host Disease - epidemiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Recombinant Proteins | Bone Marrow Transplantation - methods | Cyclophosphamide - therapeutic use | Filgrastim | Transplantation, Homologous | Bone Marrow Transplantation - immunology | Adult | Female | Transplantation Conditioning - methods | Mycophenolic Acid - administration & dosage | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Drug Administration Schedule | Graft Survival | Postoperative Complications - epidemiology | Vidarabine - analogs & derivatives | Granulocyte Colony-Stimulating Factor - therapeutic use | Postoperative Care - methods | Blood Component Transfusion | Hematologic Neoplasms - surgery | Disease-Free Survival | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Hemoglobinuria, Paroxysmal - surgery | Cyclophosphamide - pharmacology | Graft vs Host Disease - prevention & control | Aged | Vidarabine - administration & dosage | Histocompatibility | Antimitotic agents | Evaluation | Mortality | Bone marrow | Dosage and administration | Transplantation | Antineoplastic agents | T cells | Cancer | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 2011, Volume 118, Issue 9, pp. 2413 - 2419
To improve the outcome of allogeneic stem cell transplantation (allo-SCT) in multiple myeloma as part of first-line treatment, we prospectively investigated... 
CRITERIA | DEXAMETHASONE | AGENTS | HEMATOLOGY | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Graft vs Host Disease - epidemiology | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Feasibility Studies | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Antineoplastic Agents - adverse effects | Adult | Female | Hematopoietic Stem Cell Mobilization | Transplantation Conditioning - methods | Mycophenolic Acid - administration & dosage | Graft vs Host Disease - etiology | Multiple Myeloma - surgery | Immunosuppressive Agents - administration & dosage | Thalidomide - adverse effects | Drug Eruptions - etiology | Hematologic Diseases - chemically induced | Acute Disease | Immunologic Factors - administration & dosage | Combined Modality Therapy | Thalidomide - administration & dosage | Remission Induction | Cyclosporine - therapeutic use | Disease-Free Survival | Melphalan - administration & dosage | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Cyclosporine - administration & dosage | Lymphocyte Count | Aged | Immunologic Factors - adverse effects | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Immunologic Factors - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 2005, Volume 16, Issue 4, pp. 1076 - 1084
Mycophenolate mofetil (MMF) and the sequential use of cyclophosphamide followed by azathioprine (CTX-AZA) demonstrate similar short-term efficacy in the... 
GLOMERULONEPHRITIS | CONTROLLED-TRIAL | IMMUNOSUPPRESSIVE THERAPY | INTRAVENOUS CYCLOPHOSPHAMIDE | AZATHIOPRINE | UROLOGY & NEPHROLOGY | FOLLOW-UP | CLASSIFICATION | ORAL CYCLOPHOSPHAMIDE | PREDNISOLONE | ERYTHEMATOSUS | Recurrence | Azathioprine - administration & dosage | Azathioprine - therapeutic use | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Lupus Nephritis - drug therapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Incidence | Time Factors | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Prednisolone - therapeutic use | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Kidney - physiopathology | Lupus Nephritis - pathology | Drug Administration Schedule | Remission Induction | Mycophenolic Acid - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Kidney Failure, Chronic - epidemiology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Lupus Nephritis - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Survival Analysis | Azathioprine - adverse effects | Lupus Nephritis - complications | Kidney Failure, Chronic - etiology | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2014, Volume 177, Issue 1, pp. 1 - 10
Journal Article
Journal Article
Transplantation, ISSN 0041-1337, 10/2008, Volume 86, Issue 8, pp. 1043 - 1051
Journal Article
Journal Article